Consistently, targeting the catalytic subunit of the PRC2 complex, Enhancer of Zeste Homolog 2 (EZH2), led to the de-depression of enhancers controlling the pro-apoptotic B cell lymphoma-2 like 11 (BIM), thereby mediating apoptosis in breast cancer cells [96]. Here, EZH2 is linked to breast carcinoma.